A Oneindia Venture
News Personal finance Gold rates Silver rates Mutual funds IPO MSME
Gold Rates
Silver Rates
Platinum Rates
Fuel Price
Holidays
Banking
Lottery
Calculators
Savings Scheme
Get Updates
Get notified about market trends, financial advice, and investment tips!
English हिन्दी ಕನ್ನಡ മലയാളം தமிழ் తెలుగు
Sensex 73,319.55 +0.25% ↑ Nifty 22,713.10 +0.15% ↑ 22k Gold ₹ 13,835/gm Silver ₹ 2,50,000/kg Petrol ₹ 103.50 Diesel ₹ 90.03 LPG ₹ 912.50 Crude Oil $ 109.24 USD ₹ 92.71
Sensex 73,319.55 +0.25% ↑ Nifty 22,713.10 +0.15% ↑ 22k Gold ₹ 13,835/gm Silver ₹ 2,50,000/kg Petrol ₹ 103.50 Diesel ₹ 90.03 LPG ₹ 912.50 Crude Oil $ 109.24 USD ₹ 92.71
Home News Stocks
Aurobindo rallies 5 per cent following stellar Q3 results
By
Add as a preferred source on Google

aurobindo
Aurobindo Pharma: Quotes, News
BSE 1335.95BSE Quote6.15 (-0.46%)
NSE 1333.70NSE Quote8.4 (-0.63%)
Shares in Aurobindo Pharma jumped 5 per cent in trade after the company reported a good set of results for Q3 2013.
The stock was last trading at Rs 518.10, following a four fold jump in net profit. Aurobindo Pharma reported a net profit of Rs 417 crores, which was a new record for the company.

Revenues grew 81 per cent to Rs 2140, led by strong growth in the US markets.

Aurobindo Pharma is the market leader in Semi-Synthetic Penicillins and has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.

GoodReturns.in

Share This Article
Story first published: Friday, February 7, 2014, 10:56 [IST]
See More On: aurobindo pharma
Other articles published on Feb 7, 2014

More From GoodReturns

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+
Sign Out